We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Pavmed (MM) | NASDAQ:PAVMU | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 14.53 | 10.44 | 30.00 | 0 | 01:00:00 |
From Jun 2019 to Jun 2024
PAVmed Inc. (Nasdaq:PAVMU), an innovative, multi-product medical device company developing and commercializing a diversified pipeline of innovative products utilizing a groundbreaking business model focused on capital efficiency and speed to market, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive Officer, will present at the 2016 Marcum MicroCap Conference on Thursday, June 2, 2016, at 3:30pm ET taking place in New York City. Dr. Aklog will provide a corporate overview, discuss the company’s innovative business model and review PAVmed’s five lead products.
To access the live webcast of the presentation, please click here. A replay will be available following the presentation.
About PAVmed
PAVmed Inc. is an innovative, multi-product medical device company developing and commercializing a diversified pipeline of innovative products which address unmet clinical needs. The Company’s goal is to enhance and accelerate value creation by employing a business model focused on capital efficiency and speed to market. PAVmed is building a deep development product pipeline with attractive regulatory pathways and market opportunities encompassing a broad spectrum of clinical areas including carpal tunnel syndrome, medical infusions, interventional radiology, tissue ablation, and cardiovascular intervention. The Company is further expanding its pipeline through engagements with clinician innovators and leading academic medical centers.
Forward-Looking Statements
This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements, based upon the current beliefs and expectations of the Company’s management, are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160526006398/en/
For PAVmed:Investors:Matthew Ventimiglia, 212-599-1265mventimiglia@lazarpartners.comorMedia:Erich Sandoval, 213-908-6226esandoval@lazarpartners.com
1 Year Pavmed (MM) Chart |
1 Month Pavmed (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
